Traditionally used as a marker of liver function, elevated ALT levels have been linked to hepatic IR, particularly in conditions like non-alcoholic fatty liver disease (NAFLD) (38). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.